HALOVSPFSA• 3 Months (Normalized)
HALO vs PFSA (Halozyme Therapeutics Inc. vs Profusa Inc.)
Showing Closing Date Range from Jul 7 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
HALO Performance $109.86
+34.68%
Halozyme Therapeutics Inc.
Normalized Baseline0.00%
PFSA Performance $1.69
-84.96%
Profusa Inc.
Normalized Baseline0.00%
Alpha Spread Margin HALO LEADS
+119.64 pts
HALO outperforming by 119.64 percentage points
HALOPFSA
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
HALO PFSA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(63 dates)
| Date | HALO Price | HALO Gain (%) | PFSA Price | PFSA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $109.86 | +34.68% | $1.69 | -84.96% | +119.64% |
| Oct 01, 2026 | $106.94 | +31.10% | $- | - | |
| Sep 30, 2026 | $110.40 | +35.34% | $1.98 | -82.38% | +117.72% |
| Sep 29, 2026 | $111.56 | +36.77% | $2.27 | -79.80% | +116.57% |
| Sep 28, 2026 | $112.89 | +38.40% | $1.69 | -84.96% | +123.36% |
| Sep 25, 2026 | $113.90 | +39.63% | $2.18 | -80.60% | +120.23% |
| Sep 24, 2026 | $- | $3.03 | -73.04% | - | |
| Sep 23, 2026 | $112.44 | +37.84% | $2.05 | -81.76% | +119.60% |
| Sep 22, 2026 | $115.13 | +41.14% | $2.17 | -80.69% | +121.83% |
| Sep 21, 2026 | $111.45 | +36.63% | $1.94 | -82.74% | +119.37% |
| Sep 18, 2026 | $112.45 | +37.86% | $1.91 | -83.01% | +120.87% |
| Sep 17, 2026 | $109.68 | +34.46% | $1.80 | -83.99% | +118.45% |
| Sep 16, 2026 | $108.44 | +32.94% | $1.78 | -84.16% | +117.10% |
| Sep 15, 2026 | $106.25 | +30.26% | $1.83 | -83.72% | +113.98% |
| Sep 14, 2026 | $107.94 | +32.33% | $2.59 | -76.96% | +109.29% |
Page 1 of 5